nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RX4—nerve—skin cancer	0.03	0.0487	CbGeAlD
Suramin—SIRT1—nerve—skin cancer	0.0263	0.0427	CbGeAlD
Suramin—F2—leg—skin cancer	0.0256	0.0416	CbGeAlD
Suramin—F2—forelimb—skin cancer	0.0254	0.0412	CbGeAlD
Suramin—F2—hindlimb—skin cancer	0.0229	0.0371	CbGeAlD
Suramin—SIRT1—endothelium—skin cancer	0.0224	0.0364	CbGeAlD
Suramin—SIRT1—blood vessel—skin cancer	0.0207	0.0335	CbGeAlD
Suramin—P2RY2—epithelium—skin cancer	0.0196	0.0319	CbGeAlD
Suramin—F2—appendage—skin cancer	0.0196	0.0318	CbGeAlD
Suramin—FSHR—connective tissue—skin cancer	0.0195	0.0316	CbGeAlD
Suramin—P2RX4—nipple—skin cancer	0.017	0.0277	CbGeAlD
Suramin—SIRT1—nipple—skin cancer	0.0149	0.0242	CbGeAlD
Suramin—P2RY2—female reproductive system—skin cancer	0.0146	0.0237	CbGeAlD
Suramin—RYR1—nipple—skin cancer	0.0138	0.0224	CbGeAlD
Suramin—FSHR—female reproductive system—skin cancer	0.0137	0.0223	CbGeAlD
Suramin—P2RY2—head—skin cancer	0.0122	0.0198	CbGeAlD
Suramin—F2—endothelium—skin cancer	0.0118	0.0192	CbGeAlD
Suramin—F2—blood vessel—skin cancer	0.0109	0.0177	CbGeAlD
Suramin—SIRT1—connective tissue—skin cancer	0.0106	0.0172	CbGeAlD
Suramin—ARSA—connective tissue—skin cancer	0.0105	0.017	CbGeAlD
Suramin—PLA2G2A—nipple—skin cancer	0.0105	0.017	CbGeAlD
Suramin—SIRT1—epithelium—skin cancer	0.0101	0.0163	CbGeAlD
Suramin—P2RX4—mammalian vulva—skin cancer	0.00995	0.0162	CbGeAlD
Suramin—ARSA—skin of body—skin cancer	0.00945	0.0153	CbGeAlD
Suramin—SIRT5—female reproductive system—skin cancer	0.00901	0.0146	CbGeAlD
Suramin—SIRT1—mammalian vulva—skin cancer	0.00872	0.0142	CbGeAlD
Suramin—P2RX4—female reproductive system—skin cancer	0.00852	0.0138	CbGeAlD
Suramin—RYR1—mammalian vulva—skin cancer	0.00806	0.0131	CbGeAlD
Suramin—F2—neck—skin cancer	0.00781	0.0127	CbGeAlD
Suramin—SIRT1—lymphoid tissue—skin cancer	0.00774	0.0126	CbGeAlD
Suramin—ARSA—lymphoid tissue—skin cancer	0.00765	0.0124	CbGeAlD
Suramin—SIRT5—head—skin cancer	0.00753	0.0122	CbGeAlD
Suramin—SIRT1—female reproductive system—skin cancer	0.00747	0.0121	CbGeAlD
Suramin—PLA2G2A—connective tissue—skin cancer	0.00742	0.012	CbGeAlD
Suramin—ARSA—female reproductive system—skin cancer	0.00738	0.012	CbGeAlD
Suramin—PLA2G4A—nipple—skin cancer	0.00727	0.0118	CbGeAlD
Suramin—P2RX4—head—skin cancer	0.00712	0.0116	CbGeAlD
Suramin—PLA2G2A—epithelium—skin cancer	0.00704	0.0114	CbGeAlD
Suramin—RYR1—female reproductive system—skin cancer	0.0069	0.0112	CbGeAlD
Suramin—SIRT1—head—skin cancer	0.00624	0.0101	CbGeAlD
Suramin—ARSA—head—skin cancer	0.00616	0.01	CbGeAlD
Suramin—PLA2G2A—mammalian vulva—skin cancer	0.00611	0.00991	CbGeAlD
Suramin—RYR1—head—skin cancer	0.00577	0.00936	CbGeAlD
Suramin—F2—connective tissue—skin cancer	0.0056	0.00909	CbGeAlD
Suramin—PLA2G2A—lymphoid tissue—skin cancer	0.00542	0.0088	CbGeAlD
Suramin—F2—epithelium—skin cancer	0.00532	0.00863	CbGeAlD
Suramin—SIRT5—lymph node—skin cancer	0.00527	0.00856	CbGeAlD
Suramin—PLA2G2A—female reproductive system—skin cancer	0.00523	0.00849	CbGeAlD
Suramin—PLA2G4A—connective tissue—skin cancer	0.00516	0.00837	CbGeAlD
Suramin—P2RX4—lymph node—skin cancer	0.00499	0.00809	CbGeAlD
Suramin—SIRT1—lymph node—skin cancer	0.00437	0.00709	CbGeAlD
Suramin—PLA2G2A—head—skin cancer	0.00437	0.00709	CbGeAlD
Suramin—ARSA—lymph node—skin cancer	0.00432	0.007	CbGeAlD
Suramin—PLA2G4A—mammalian vulva—skin cancer	0.00425	0.00689	CbGeAlD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00422	0.011	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—RASA1—skin cancer	0.00413	0.0108	CbGpPWpGaD
Suramin—F2—lymphoid tissue—skin cancer	0.00409	0.00664	CbGeAlD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00408	0.0106	CbGpPWpGaD
Suramin—F2—female reproductive system—skin cancer	0.00395	0.00641	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—CDK4—skin cancer	0.00393	0.0102	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.0037	0.00965	CbGpPWpGaD
Suramin—PLA2G4A—female reproductive system—skin cancer	0.00364	0.0059	CbGeAlD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.00345	0.00898	CbGpPWpGaD
Suramin—F2—head—skin cancer	0.0033	0.00535	CbGeAlD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.00327	0.00851	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00324	0.00844	CbGpPWpGaD
Suramin—SIRT1—Negative epigenetic regulation of rRNA expression—ERCC2—skin cancer	0.00323	0.00842	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—MC1R—skin cancer	0.00321	0.00837	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—EXOC2—skin cancer	0.00317	0.00825	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00313	0.00815	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—MC1R—skin cancer	0.0031	0.00809	CbGpPWpGaD
Suramin—PLA2G2A—lymph node—skin cancer	0.00306	0.00497	CbGeAlD
Suramin—SIRT1—Regulation of retinoblastoma protein—CDKN2A—skin cancer	0.003	0.00783	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00293	0.00763	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RASA1—skin cancer	0.00289	0.00753	CbGpPWpGaD
Suramin—SIRT1—Epigenetic regulation of gene expression—ERCC2—skin cancer	0.00287	0.00747	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00278	0.00723	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—CDKN2A—skin cancer	0.00277	0.00722	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RHOU—skin cancer	0.00276	0.00719	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00271	0.00706	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00268	0.00698	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RHOU—skin cancer	0.00267	0.00694	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class III—TP53—skin cancer	0.00255	0.00664	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—SHH—skin cancer	0.00229	0.00597	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PTCH2—skin cancer	0.00228	0.00594	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—FOXO4—skin cancer	0.00223	0.0058	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—SHH—skin cancer	0.00221	0.00576	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PTCH2—skin cancer	0.0022	0.00574	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—SMO—skin cancer	0.00217	0.00566	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—PTCH1—skin cancer	0.00217	0.00566	CbGpPWpGaD
Suramin—PLA2G4A—lymph node—skin cancer	0.00213	0.00345	CbGeAlD
Suramin—P2RY2—GPCR ligand binding—PTGER4—skin cancer	0.00211	0.00551	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—SMO—skin cancer	0.0021	0.00546	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—PTCH1—skin cancer	0.0021	0.00546	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—PTGER4—skin cancer	0.00204	0.00532	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.00203	0.00528	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00189	0.00492	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—MC1R—skin cancer	0.00182	0.00473	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—MC1R—skin cancer	0.0018	0.00468	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.00179	0.00467	CbGpPWpGaD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.00179	0.00466	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CDK4—skin cancer	0.00177	0.00462	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—MC1R—skin cancer	0.00175	0.00457	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.00168	0.00438	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MC1R—skin cancer	0.00165	0.0043	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—RASA1—skin cancer	0.00163	0.00424	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—CDK4—skin cancer	0.00161	0.0042	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MC1R—skin cancer	0.00159	0.00415	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—skin cancer	0.00158	0.00412	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTCH2—skin cancer	0.00135	0.00351	CbGpPWpGaD
Suramin—ARSA—Metabolism—PLIN2—skin cancer	0.0013	0.0034	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTCH2—skin cancer	0.0013	0.00339	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CDK4—skin cancer	0.0013	0.00338	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTCH2—skin cancer	0.00127	0.00331	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—PTGS2—skin cancer	0.00127	0.0033	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00121	0.00314	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.0012	0.00313	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—PTGER4—skin cancer	0.00119	0.00311	CbGpPWpGaD
Suramin—PLA2G4A—Arachidonic acid metabolism—PTGS2—skin cancer	0.00119	0.00309	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—SHH—skin cancer	0.00118	0.00306	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.00117	0.00304	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—PTGER4—skin cancer	0.00115	0.00301	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—SHH—skin cancer	0.00113	0.00296	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PTCH1—skin cancer	0.00111	0.0029	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—SMO—skin cancer	0.00111	0.0029	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.00111	0.00288	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.0011	0.00287	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PTGER4—skin cancer	0.00108	0.00283	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PTCH1—skin cancer	0.00108	0.0028	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—SMO—skin cancer	0.00108	0.0028	CbGpPWpGaD
Suramin—ARSA—Metabolism—CSPG4—skin cancer	0.00105	0.00274	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—EXOC2—skin cancer	0.00105	0.00274	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PTGER4—skin cancer	0.00105	0.00273	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GLI2—skin cancer	0.00102	0.00266	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CDKN2A—skin cancer	0.000991	0.00258	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GLI2—skin cancer	0.000986	0.00257	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MC1R—skin cancer	0.000974	0.00254	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.00097	0.00253	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GLI1—skin cancer	0.00096	0.0025	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000947	0.00247	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MC1R—skin cancer	0.000941	0.00245	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.00094	0.00245	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GLI1—skin cancer	0.000927	0.00242	CbGpPWpGaD
Suramin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—skin cancer	0.00092	0.0024	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—MC1R—skin cancer	0.000918	0.00239	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SUFU—skin cancer	0.00091	0.00237	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000889	0.00232	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000884	0.0023	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SUFU—skin cancer	0.000879	0.00229	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000862	0.00225	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLIN2—skin cancer	0.000841	0.00219	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—PTGS2—skin cancer	0.000826	0.00215	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—HRAS—skin cancer	0.000824	0.00215	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000805	0.0021	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000804	0.00209	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000793	0.00207	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RHOU—skin cancer	0.000789	0.00205	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000771	0.00201	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—skin cancer	0.000755	0.00197	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RHOU—skin cancer	0.000721	0.00188	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—skin cancer	0.000715	0.00186	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000715	0.00186	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—BRAF—skin cancer	0.000706	0.00184	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IL6—skin cancer	0.000696	0.00181	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SHH—skin cancer	0.000694	0.00181	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL6—skin cancer	0.000691	0.0018	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RASA1—skin cancer	0.00069	0.0018	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—skin cancer	0.000686	0.00179	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CSPG4—skin cancer	0.000678	0.00177	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—BRAF—skin cancer	0.000671	0.00175	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SHH—skin cancer	0.00067	0.00175	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RASA1—skin cancer	0.000666	0.00174	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTCH1—skin cancer	0.000658	0.00171	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SMO—skin cancer	0.000658	0.00171	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SHH—skin cancer	0.000654	0.0017	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTCH2—skin cancer	0.000652	0.0017	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTGER4—skin cancer	0.000641	0.00167	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTCH1—skin cancer	0.000636	0.00166	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SMO—skin cancer	0.000636	0.00166	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—IL6—skin cancer	0.000628	0.00164	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTCH1—skin cancer	0.00062	0.00162	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—SMO—skin cancer	0.00062	0.00162	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—skin cancer	0.000619	0.00161	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTGER4—skin cancer	0.000619	0.00161	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTGER4—skin cancer	0.000604	0.00157	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTCH2—skin cancer	0.000596	0.00155	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—NRAS—skin cancer	0.000585	0.00152	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—skin cancer	0.000576	0.0015	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000569	0.00148	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—skin cancer	0.000566	0.00148	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FOXO4—skin cancer	0.000566	0.00147	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—HRAS—skin cancer	0.000562	0.00146	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000559	0.00146	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—skin cancer	0.000552	0.00144	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FOXO4—skin cancer	0.000547	0.00142	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—MC1R—skin cancer	0.000519	0.00135	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—skin cancer	0.000505	0.00132	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—KRAS—skin cancer	0.000503	0.00131	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ERCC2—skin cancer	0.000479	0.00125	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MC1R—skin cancer	0.000471	0.00123	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—skin cancer	0.000461	0.0012	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—skin cancer	0.00045	0.00117	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—skin cancer	0.000444	0.00116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MC1R—skin cancer	0.000431	0.00112	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—HRAS—skin cancer	0.000428	0.00111	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—NRAS—skin cancer	0.000422	0.0011	CbGpPWpGaD
Suramin—ARSA—Metabolism—ERCC2—skin cancer	0.000415	0.00108	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000406	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PLIN2—skin cancer	0.000396	0.00103	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH2—skin cancer	0.000385	0.001	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—KRAS—skin cancer	0.000382	0.000995	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TERT—skin cancer	0.000378	0.000985	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TERT—skin cancer	0.000365	0.000951	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—KRAS—skin cancer	0.000363	0.000946	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00036	0.000938	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH2—skin cancer	0.000352	0.000918	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PTGER4—skin cancer	0.000341	0.000889	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SHH—skin cancer	0.000336	0.000875	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—skin cancer	0.000325	0.000846	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CSPG4—skin cancer	0.000319	0.000832	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—NRAS—skin cancer	0.000318	0.00083	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTCH1—skin cancer	0.000318	0.000829	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SMO—skin cancer	0.000318	0.000829	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000314	0.000819	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTGER4—skin cancer	0.00031	0.000807	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—NRAS—skin cancer	0.000308	0.000801	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SHH—skin cancer	0.000307	0.0008	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BRAF—skin cancer	0.000299	0.00078	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GLI2—skin cancer	0.000292	0.00076	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SMO—skin cancer	0.000291	0.000759	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTCH1—skin cancer	0.000291	0.000759	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BRAF—skin cancer	0.000289	0.000753	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTGER4—skin cancer	0.000283	0.000738	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MC1R—skin cancer	0.000278	0.000725	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GLI1—skin cancer	0.000274	0.000715	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—KRAS—skin cancer	0.000274	0.000714	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000272	0.000709	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000271	0.000705	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ERCC2—skin cancer	0.000268	0.000697	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GLI2—skin cancer	0.000267	0.000695	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—KRAS—skin cancer	0.000265	0.00069	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SUFU—skin cancer	0.00026	0.000678	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MC1R—skin cancer	0.000255	0.000663	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GLI1—skin cancer	0.000251	0.000654	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—skin cancer	0.000249	0.000649	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000242	0.00063	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SUFU—skin cancer	0.000238	0.00062	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—skin cancer	0.000233	0.000607	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00023	0.000599	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—skin cancer	0.000225	0.000586	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—skin cancer	0.000223	0.000581	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00022	0.000574	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—skin cancer	0.000217	0.000565	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—skin cancer	0.000215	0.000561	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SHH—skin cancer	0.000198	0.000517	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RASA1—skin cancer	0.000197	0.000514	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRAS—skin cancer	0.000188	0.00049	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH1—skin cancer	0.000188	0.00049	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMO—skin cancer	0.000188	0.00049	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTGER4—skin cancer	0.000183	0.000477	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRAS—skin cancer	0.000182	0.000473	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SHH—skin cancer	0.000181	0.000473	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RASA1—skin cancer	0.00018	0.00047	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH1—skin cancer	0.000172	0.000448	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMO—skin cancer	0.000172	0.000448	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00017	0.000442	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTGER4—skin cancer	0.000167	0.000436	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—skin cancer	0.000162	0.000422	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FOXO4—skin cancer	0.000162	0.000421	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—skin cancer	0.00016	0.000418	CbGpPWpGaD
Suramin—F2—Hemostasis—NRAS—skin cancer	0.000159	0.000413	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—skin cancer	0.000156	0.000407	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FOXO4—skin cancer	0.000148	0.000385	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NRAS—skin cancer	0.000145	0.000378	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—skin cancer	0.000144	0.000375	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—skin cancer	0.000139	0.000362	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—skin cancer	0.000138	0.000359	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—skin cancer	0.000136	0.000356	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—skin cancer	0.000133	0.000346	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—skin cancer	0.000132	0.000343	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—skin cancer	0.000127	0.000331	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ERCC2—skin cancer	0.000126	0.000328	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—skin cancer	0.000125	0.000325	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—skin cancer	0.000121	0.000316	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—skin cancer	0.000116	0.000302	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—skin cancer	0.000111	0.000289	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TERT—skin cancer	0.000108	0.000281	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—skin cancer	0.000106	0.000276	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TERT—skin cancer	9.88e-05	0.000257	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NRAS—skin cancer	9.1e-05	0.000237	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BRAF—skin cancer	8.55e-05	0.000223	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NRAS—skin cancer	8.32e-05	0.000217	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—skin cancer	7.83e-05	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BRAF—skin cancer	7.82e-05	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—skin cancer	7.56e-05	0.000197	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—skin cancer	7.16e-05	0.000187	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—skin cancer	6.66e-05	0.000173	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—skin cancer	6.37e-05	0.000166	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—skin cancer	6.09e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—skin cancer	5.83e-05	0.000152	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRAS—skin cancer	5.38e-05	0.00014	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRAS—skin cancer	4.92e-05	0.000128	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—skin cancer	4.63e-05	0.000121	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—skin cancer	4.23e-05	0.00011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—skin cancer	4.11e-05	0.000107	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—skin cancer	3.93e-05	0.000102	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—skin cancer	3.76e-05	9.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—skin cancer	3.76e-05	9.8e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—skin cancer	3.6e-05	9.37e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—skin cancer	3.44e-05	8.97e-05	CbGpPWpGaD
